CO5241364A1 - Vacunas la zoster - Google Patents

Vacunas la zoster

Info

Publication number
CO5241364A1
CO5241364A1 CO00002923A CO00002923A CO5241364A1 CO 5241364 A1 CO5241364 A1 CO 5241364A1 CO 00002923 A CO00002923 A CO 00002923A CO 00002923 A CO00002923 A CO 00002923A CO 5241364 A1 CO5241364 A1 CO 5241364A1
Authority
CO
Colombia
Prior art keywords
protein
zoster
vaccines
active fragment
immunologically active
Prior art date
Application number
CO00002923A
Other languages
English (en)
Inventor
Alex Bollen
Michelle Haumont
Paul Jacobs
Alain Jacquet
Georges Francis Massaer Marc
Original Assignee
Smithkline Beechman Biolog S A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beechman Biolog S A filed Critical Smithkline Beechman Biolog S A
Publication of CO5241364A1 publication Critical patent/CO5241364A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16722—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16734—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Una proteína de fusión que comprende (1) una proteína gE del Virus de la Varicela Zoster o un fragmento inmunológicamente activo de la misma fusionados a (2) una proteína diferente del Virus de la Varicela Zoster o un fragmento inmunológicamente activo de la misma. Un procedimiento para la producción de una proteína de fusión de acuerdo con la reivindicación 1 o la reivindicación 2, que comprende expresar un ADN recombinante que codifica dicha proteína en una célula hospedadora y recuperar la proteína.
CO00002923A 1999-01-20 2000-01-20 Vacunas la zoster CO5241364A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9901254.4A GB9901254D0 (en) 1999-01-20 1999-01-20 Vaccines

Publications (1)

Publication Number Publication Date
CO5241364A1 true CO5241364A1 (es) 2003-01-31

Family

ID=10846213

Family Applications (1)

Application Number Title Priority Date Filing Date
CO00002923A CO5241364A1 (es) 1999-01-20 2000-01-20 Vacunas la zoster

Country Status (5)

Country Link
AR (1) AR027484A1 (es)
AU (1) AU2292600A (es)
CO (1) CO5241364A1 (es)
GB (1) GB9901254D0 (es)
WO (1) WO2000043527A1 (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2012213948B2 (en) * 2005-03-03 2016-01-21 Glaxosmithkline Biologicals S.A. Vaccine
GB0504436D0 (en) * 2005-03-03 2005-04-06 Glaxosmithkline Biolog Sa Vaccine
KR20100063030A (ko) * 2007-07-19 2010-06-10 노바백스, 인코포레이티드 바리셀라 조스터 바이러스-바이러스 유사 입자(ＶＬＰｓ) 및 항원
CA2826199A1 (en) * 2011-01-31 2012-08-09 The Trustees Of The University Of Pennsylvania Nucleic acid molecules encoding novel herpes antigens, vaccine comprising the same, and methods of use thereof
KR101723605B1 (ko) * 2014-10-21 2017-04-07 진원생명과학 주식회사 대상포진 예방 및 치료용 dna 백신 조성물 및 이를 이용한 vzv 항원에 대한 t세포 활성화 방법
US10874734B2 (en) 2016-11-25 2020-12-29 Mogam Institute For Biomedical Research Varicella zoster virus vaccine
WO2018097642A1 (ko) * 2016-11-25 2018-05-31 재단법인 목암생명과학연구소 바리셀라 조스터 바이러스 백신
CN112142828B (zh) * 2019-06-28 2022-02-01 怡道生物科技(苏州)有限公司 一种gE基因及表达该基因的载体
EP4074334A4 (en) * 2019-12-13 2024-09-04 Grand Theravac Life Science Nanjing Co Ltd PHARMACEUTICAL COMPOSITION AND ITS USE
CN115819616A (zh) * 2021-07-28 2023-03-21 江苏瑞科生物技术股份有限公司 一种基因重组vzv融合蛋白及其制备方法和应用
AU2022397292A1 (en) 2021-11-24 2024-05-30 Flagship Pioneering Innovations Vi, Llc Varicella-zoster virus immunogen compositions and their uses
CN114891830B (zh) * 2022-04-02 2024-03-01 武汉博沃生物科技有限公司 基于水痘-带状疱疹病毒的重组表达载体、重组病毒及用途
WO2024153235A1 (zh) * 2023-01-19 2024-07-25 厦门大学 一种水痘-带状疱疹病毒gE和gI的融合蛋白及应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CY1933A (en) * 1989-06-27 1990-06-22 Smithkline Biolog Novel compounds
GB9226768D0 (en) * 1992-12-23 1993-02-17 Smithkline Beecham Biolog Vaccines
GB9413751D0 (en) * 1994-07-07 1994-08-24 British Bio Technology Immunodominant peptides
TR199801531T2 (xx) * 1996-02-09 1998-10-21 Smithkline Beecham Biologicals S.A. Zoster vir�s geni ve �r�n�ne kar�� a��lar.

Also Published As

Publication number Publication date
GB9901254D0 (en) 1999-03-10
AU2292600A (en) 2000-08-07
WO2000043527A1 (en) 2000-07-27
AR027484A1 (es) 2003-04-02

Similar Documents

Publication Publication Date Title
CO5241364A1 (es) Vacunas la zoster
ATE454393T1 (de) Egvii-endoglucanase und dafür codierende nukleinsäuren
NO964862D0 (no) Papillomavirusvaksiner
DK0871482T3 (da) Rekombinante vesiculovirus og deres anvendelser
SE9003978D0 (sv) Dna expressionssystem baserade paa ett virus replikon
GEP20084431B (en) Papilloma virus vaccine
ES2061708T3 (es) Virus recombinante de la viruela de la gallina, vectores de expresion de proteinas heterologas y vacunas para aves de corral derivadas de este virus.
WO2003091401A3 (en) Multi plasmid system for the production of influenza virus
BR9813608B1 (pt) célula hospedeira de bacillus transgênica, e, processo para produzir um polipeptìdeo tendo atividade aminopeptidase.
DK0894126T3 (da) Alkalisk phosphatase-deficient trådformet svamp
MXPA02006888A (es) Flavivirus recombinantes y metodos para utilizar los mismos.
DE60117919D1 (de) Fusionsprotein mit verbesserter in vivo erythropoietinwirkung
DK0484382T3 (da) Felint calicivirus-capsid-protein og nucleotidsekvens
CY1106433T1 (el) Εμβολια κοκκιδιωσης
CY1107431T1 (el) Σωματιδια για γoνιδιακη θεραπεια
EP0256677A3 (en) Pseudorabies virus recombinants and their use in the production of proteins
ATE427119T1 (de) Rekombinante tollwut-vakzine und verfahren zu ihrer herstellung und verwendung
PT97427A (pt) Processo para a preparacao de proteinas de fusao de tendamistato em estreptomicetas
ES2073777T3 (es) Inhibicion de la replicacion virica.
DE60042922D1 (de) Virale expressionsvektoren für pflanzen
DE60027581D1 (de) Design von immunogene
ES2367245T8 (es) Virus recombinante que expresa adn foráneo que codifica cd80 felino, cd28 felino, ctla-4felino o cd86 felino y usos del mismo.
AR024212A1 (es) Virus celo recombinante y adn de virus celo.
WO2001078789A3 (en) Poliovirus replicons encoding therapeutic agents and uses thereof
AR248047A1 (es) Procedimiento para la preparacion de una vacuna a base de virus del herpes bovina modificado tipo 1.

Legal Events

Date Code Title Description
FA Application withdrawn